Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Two Doses IV Magnesium Sulfate +/- Budesonide in Severe Asthma
NCT02455687Phase 3Recruiting
- Sponsor
- Hamad Medical Corporation
- Start
- Jun 2015
- Primary completion
- Dec 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of magnesium sulfate, budesonide in asthma, sponsored by Hamad Medical Corporation. Started Jun 2015; status: recruiting.
02
Drugs
magnesium sulfatebudesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02455687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02455687.